Paolo Tarantino, MD, and Matteo Lambertini, MD, PhD discuss findings related to CDK4/6 inhibitors and antibody drug conjugates presented at SABCS 2024.
Recent Episodes
Advertisement
Authors of an article published in ONCOLOGY® detail how a novel multidisciplinary lifestyle medicine clinic can meet the needs of cancer survivors.
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Subcutaneous Daratumumab Combination in NDMM
2
Cancer Vaccine Trial Receives FDA IND Clearance in Advanced Melanoma
3
Developers Resubmit NDA for Rivoceranib/Camrelizumab in Unresectable HCC
4
Trispecific Antibody Earns FDA Fast Track Designation in Multiple Myeloma
5